| Authors: |
Al Awaidy ST; Middle East, Africa, and Eurasia Influenza Stakeholder Network (MENA-ISN), P.O.Box 393 PC 100, Muscat, Oman. salah.awaidy@gmail.com., Koul PA; Middle East, Africa, and Eurasia Influenza Stakeholder Network (MENA-ISN), P.O.Box 393 PC 100, Muscat, Oman.; Internal and Pulmonary Medicine Department, Sheri Kashmir Institute of Medical Sciences, Srinagar, India., Khamis F; Adult Infectious Diseases, Department of Medicine, Royal Hospital, MOH, Muscat, Oman., Al Slil F; Middle East, Africa, and Eurasia Influenza Stakeholder Network (MENA-ISN), P.O.Box 393 PC 100, Muscat, Oman.; Directorate of the National Diabetes Prevention and Control Program, Ministry of Health, Riyadh, Saudi Arabia., Jroundi I; Middle East, Africa, and Eurasia Influenza Stakeholder Network (MENA-ISN), P.O.Box 393 PC 100, Muscat, Oman.; Faculty of Medicine and Pharmacy of Rabat, Mohammed V University, Rabat, Morocco., Al Olama F; Child Health section, Dubai Health Authority, Dubai, UAE., Elawad KH; Health Protection, Primary Health Care Center, MOPH, Doha, Qatar., Abuhasan MYH; Department of National immunization Program, Ministry of Health, Riyadh, Kingdom of Saudi Arabia., Al Oraimi F; Health Affairs, Muscat MOH, Oman., Tanriover MD; Middle East, Africa, and Eurasia Influenza Stakeholder Network (MENA-ISN), P.O.Box 393 PC 100, Muscat, Oman.; Department of Internal Medicine, Division of General Internal Medicine, Hacettepe University Faculty of Medicine, Ankara, Turkey., Zaraket H; Middle East, Africa, and Eurasia Influenza Stakeholder Network (MENA-ISN), P.O.Box 393 PC 100, Muscat, Oman.; Department of Experimental Pathology, Immunology, and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. |
